期刊文献+

RNA interference and antiviral therapy 被引量:14

RNA interference and antiviral therapy
下载PDF
导出
摘要 RNA interference (RNAi) is an evolutionally conserved gene silencing mechanism present in a variety of eukaryotic species. RNAi uses short double-stranded RNA (dsRNA) to trigger degradation or translation repression of homologous RNA targets in a sequence-specific manner. This system can be induced effectively in vitro and in vivo by direct application of small interfering RNAs (siRNAs), or by expression of short hairpin RNA (shRNA) with non-viral and viral vectors. To date, RNAi has been extensively used as a novel and effective tool for functional genomic studies, and has displayed great potential in treating human diseases, including human genetic and acquired disorders such as cancer and viral infections. In the present review, we focus on the recent development in the use of RNAi in the prevention and treatment of viral infections. The mechanisms, strategies, hurdles and prospects of employing RNAi in the pharmaceutical industry are also discussed. RNA interference (RNAi) is an evolutionally conserved gene silencing mechanism present in a variety of eukaryotic species. RNAi uses short double-stranded RNA (dsRNA) to trigger degradation or translation repression of homologous RNA targets in a sequence-specific manner. This system can be induced effectively in vitro and in vivo by direct application of small interfering RNAs (siRNAs), or by expression of short hairpin RNA (shRNA) with non-viral and viral vectors. To date, RNAi has been extensively used as a novel and effective tool for functional genomic studies, and has displayed great potential in treating human diseases, including human genetic and acquired disorders such as cancer and viral infections. In the present review, we focus on the recent development in the use of RNAi in the prevention and treatment of viral infections. The mechanisms, strategies, hurdles and prospects of employing RNAi in the pharmaceutical industry are also discussed.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第39期5169-5179,共11页 世界胃肠病学杂志(英文版)
基金 RFCID, No 01030152, RGC, CUHK4428/06M, ITF ITS091/03 of Hong Kong Government, and Faculty Direct Fund of the Chinese University of Hong Kong
  • 相关文献

参考文献3

二级参考文献111

  • 1Fu-Sheng Wang Li-He Xing Ming-Xu Liu Chuan-Lin Zhu Hui-Gang Liu Hui-Fen Wang Zhou-Yun Lei Division of Biological Engineering,~2 Fourth Department of Liver Diseases,Beijing Institute of Infectious Diseases,Beijing Hospital of Infectious Diseases,Beijing 100039,China.Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection[J].World Journal of Gastroenterology,2001,7(4):537-541. 被引量:131
  • 2MinChen,Yong-GuoLi,Da-ZhiZhang,Zhi-YiWang,Wei-QunZeng,Xiao-FengShi,YuanGuo,Shu-HuaGuo,HongRen.Therapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: A clinical study[J].World Journal of Gastroenterology,2005,11(12):1806-1808. 被引量:40
  • 3[1]Fire A, Xu S, Montgomery MK, et al. Potent and specific genetics interference by double-stranded RNA in Caenorhabitis elegans. Nature 1998; 391:806-11. 被引量:1
  • 4[2]Jorgensen R. Altered gene expression in plants due to trans interactions between homologous genes. Trends Biotechnol 1990; 8:340-4. 被引量:1
  • 5[3]Romano N, Macino G. Quelling: transient inactivation of gene expression in Neurospora crassa by transformation with homologous sequences. Mol Microbiol 1992; 6: 3343-53. 被引量:1
  • 6[4]Dave RS, Pomerantz RJ. RNA interference: on the to an to alternate therapeutic strategy. Rev Med Virol 2003; 13: 373-85. 被引量:1
  • 7[5]Plasterk RA. RNA silencing: the genome's immune system.Science, 2002; 296: 1263-5. 被引量:1
  • 8[6]Yin JQ, Wan Y. siRNA-mediated gene regulation system. Int J Mol Med 2002; 10:355-65. 被引量:1
  • 9[7]Yin JQ, Cao JS, Shao RG, et al. SiRNA agents inhibit oncogene expression and attenuate human tumor cell growth. J Exp Ther Onc 2003; 3:1-11. 被引量:1
  • 10[8]Liu TG, Yin JQ, Shang BY, et al. Silencing of hdm2 oncogene by siRNA inhibits p53-dependent human breast cancer. Cancer Gene Therapy (In Press). 被引量:1

共引文献64

同被引文献33

引证文献14

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部